Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1992-12-21
pubmed:abstractText
To compare the efficacy and safety of oral acyclovir (400 mg twice daily) with oral isoprinosine (500 mg twice daily) in the suppression of recurrent genital herpes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-2473952, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-2578707, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-2895840, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-3910546, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-3912972, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-6125728, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-6146006, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-6328297, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-6355053, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-6368877, http://linkedlifedata.com/resource/pubmed/commentcorrection/1385295-638718
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0266-4348
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
312-6
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
pubmed:affiliation
Department of GU Medicine, Royal Hallamshire Hospital, Sheffield, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study